Application of a Microfluidic Chip-based 3D Co-culture to Test Drug Sensitivity for Individualized Treatment of Lung CancerWednesday, 13 November 2013 at 17:20 Add to Calendar ▼2013-11-13 17:20:002013-11-13 18:20:00Europe/LondonApplication of a Microfluidic Chip-based 3D Co-culture to Test Drug Sensitivity for Individualized Treatment of Lung CancerSELECTBIOenquiries@selectbiosciences.com Individualized treatment is a promising clinical strategy for lung cancer, and drug sensitivity testing is fundamental to this scheme. We aimed to develop an effective drug sensitivity test platform to support individualized treatment. |